Literature DB >> 33658900

Comparison of the Psychometric Properties of Three Fatigue Scales in Persian-Speaking Patients with Multiple Sclerosis.

Shabnam Behrangrad, Amin Kordi Yoosefinejad.   

Abstract

BACKGROUND: Fatigue is the most disabling symptom in patients with multiple sclerosis (MS). Although there is no standard tool to evaluate fatigue in clinical settings, the Fatigue Impact Scale (FIS), Fatigue Severity Scale (FSS), and Multidimensional Assessment of Fatigue (MAF) scale are popular instruments for this purpose. The aim of this study was to compare the psychometric properties of the Persian versions of these scales.
METHODS: One hundred thirty adult patients with MS and 60 controls participated in this study. They completed the scales on two occasions 3 days apart. Reproducibility and internal consistency were evaluated as intraclass correlation coefficients (ICCs) and Cronbach α. Convergent validity was assessed by evaluating the association of the fatigue scales with age, sex, Expanded Disability Status Scale (EDSS) score, disease duration, and sleep quality. Dimensionality was evaluated using confirmatory factor analysis. Acceptability and known-group validity were investigated. The effect size of each scale was computed.
RESULTS: The ICC of all instruments was 0.99. Internal consistency was 0.97 for the MAF scale, 0.93 for FSS, and 0.83 for FIS. The instruments showed moderate-to-good correlations with Pittsburgh Sleep Quality Index, EDSS score, and disease duration. Acceptability was acceptable. The FIS had three dimensions, and the FSS and MAF scale were unidimensional. All scales were able to discriminate patients with MS from controls.
CONCLUSIONS: The Persian version of the MAF scale seems to be the most suitable instrument to evaluate fatigue in patients with MS based on its time efficiency, effect size, and detailed data about various aspects of fatigue.
© 2021 Consortium of Multiple Sclerosis Centers.

Entities:  

Keywords:  Fatigue; Fatigue Impact Scale; Fatigue Severity Scale; Multidimensional Assessment of Fatigue scale; Multiple sclerosis (MS)

Year:  2020        PMID: 33658900      PMCID: PMC7906033          DOI: 10.7224/1537-2073.2019-051

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  41 in total

Review 1.  Evaluating patient-based outcome measures for use in clinical trials.

Authors:  R Fitzpatrick; C Davey; M J Buxton; D R Jones
Journal:  Health Technol Assess       Date:  1998       Impact factor: 4.014

2.  Psychometric properties of the modified fatigue impact scale.

Authors:  Rebecca D Larson
Journal:  Int J MS Care       Date:  2013

3.  The relationship between fatigue and other clinical features of multiple sclerosis.

Authors:  Roger J Mills; Carolyn A Young
Journal:  Mult Scler       Date:  2010-12-06       Impact factor: 6.312

4.  Validity of a French version of the fatigue impact scale in multiple sclerosis.

Authors:  M Debouverie; S Pittion-Vouyovitch; S Louis; F Guillemin
Journal:  Mult Scler       Date:  2007-09       Impact factor: 6.312

Review 5.  Fatigue: an overview.

Authors:  Thomas C Rosenthal; Barbara A Majeroni; Richard Pretorius; Khalid Malik
Journal:  Am Fam Physician       Date:  2008-11-15       Impact factor: 3.292

6.  A medical definition of fatigue in multiple sclerosis.

Authors:  R J Mills; C A Young
Journal:  QJM       Date:  2008-01-14

7.  Multiple sclerosis in Pakistan.

Authors:  M Wasay; S Ali; I A Khatri; A Hassan; M Asif; N Zakiullah; A Ahmed; A Malik; B Khealani; A Haq; S Fredrikson
Journal:  Mult Scler       Date:  2007-02-09       Impact factor: 6.312

8.  Evaluation of the Persian version of modified fatigue impact scale in Iranian patients with multiple sclerosis.

Authors:  Mohammad Hossein Harirchian; Somayeh Nasergivechi; Marzieh Maddah; Alipasha Meysamie; Homayoun Amini; Ehsan Esmaelii Shandiz; Abbas Tafakhori
Journal:  Iran J Neurol       Date:  2013

9.  The relationship between fatigability and sleep quality in people with multiple sclerosis.

Authors:  Mayis Aldughmi; Jessie Huisinga; Sharon G Lynch; Catherine F Siengsukon
Journal:  Mult Scler J Exp Transl Clin       Date:  2016-12-07

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  1 in total

1.  Analysis of the extent of limbic system changes in multiple sclerosis using FreeSurfer and voxel-based morphometry approaches.

Authors:  Amanda Frisosky Abuaf; Samuel R Bunting; Sara Klein; Timothy Carroll; Jake Carpenter-Thompson; Adil Javed; Veronica Cipriani
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.